MiR-29b may possibly disrupt glucose metabolism and suppress epithelial ovarian most cancers expansion by lowering AKT2-AKT3 and PKM2 concentrations Targeting PKM2 by means of stabilization of miR-122 in colon most cancers may well improve the success of chemotherapy in colon cancer HPASMCs were being obtained from ScienCell corporation (Carlsbad, United https://aleisters999gse2.ttblogs.com/profile